Sign up to save your podcasts
Or
Share Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
View all episodes
By HFMA
4.2
4141 ratings
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
More shows like HFMA’s Voices in Healthcare Finance
View all
WSJ What’s News
4,358 Listeners
HBR IdeaCast
1,830 Listeners
Planet Money
30,839 Listeners
The Hospital Finance Podcast
36 Listeners
Make Me Smart
5,497 Listeners
The Daily
111,864 Listeners
Up First from NPR
56,221 Listeners
KFF Health News' 'What the Health?'
478 Listeners
Worklife with Adam Grant
9,188 Listeners
Becker’s Healthcare Podcast
184 Listeners
Tradeoffs
391 Listeners
Hard Fork
5,448 Listeners
ReThinking
610 Listeners
The Morgan Housel Podcast
987 Listeners
Healthcare Blame Game
6 Listeners
WSJ's Take On the Week
132 Listeners